ProCE Banner Activity

My Thoughts on the Evolving Landscape of PARP Inhibitors and the Role of Biomarkers in Ovarian Cancer

Clinical Thought
Read this expert commentary to gain practical clinical insights on the current treatment landscape of PARP inhibitors and the role of biomarkers in ovarian cancer.

Released: November 02, 2021

Expiration: November 01, 2022

Share

Faculty

Nicoletta Colombo

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca